Hospital da Bahia

Salvador BA, 41820-011

1 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Diseases, Coronary Artery Disease, Coronary Disease, Elevated Lp(a), Extragonadal Yolk Sac Tumors, Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer, Heart Diseases, Local Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma

Studies at this site

• A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed